GGrantIndex
← Search

Targeted Clincial Trials to Reduce the Risk of Antimocribal Resistance

$2,434,268N01FY2015AINIH

Wayne State University, Detroit MI

Investigators

Abstract

To evaluate strategies that test the safety and effectiveness of therapeutic approaches/regimens to reduce the probability of the emergence of antibiotic drug resistance by minimizing unnecessary drug exposure.

View original record on NIH RePORTER →
Targeted Clincial Trials to Reduce the Risk of Antimocribal Resistance · GrantIndex